Survival, development and food energy partitioning of nase larvae and early juveniles at different temperatures von Keckeis, H, Kamler, E, Bauer-Nemeschkal, E, Schneeweiss, K

Volltext

Survival, development and food energy partitioning of nase larvae and early juveniles at different temperatures von Keckeis, H., Kamler, E., Bauer-Nemeschkal, E., Schneeweiss, K.

Volltext

IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease von Taube, C, Tertilt, C, Gyülveszi, G, Dehzad, N, Kreymborg, K, Schneeweiss, K, Michel, E, Reuter, S, Renauld, J C, Arnold-Schild, D, Schild, H, Buhl, R, Becher, B

Volltext

Survival, development and food energy partitioning of nase larvae and early juveniles at different temperatures

Volltext

Evolutionary Consequences, Constraints and Potential of Polyploidy in Plants von Weiss-Schneeweiss, H., Emadzade, K., Jang, T.-S., Schneeweiss, G.M.

Volltext

Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response—final results from GeparSixto von Loibl, S., Weber, K.E., Timms, K.M., Elkin, E.P., Hahnen, E., Fasching, P.A., Lederer, B., Denkert, C., Schneeweiss, A., Braun, S., Salat, C.T., Rezai, M., Blohmer, J.U., Zahm, D.M., Jackisch, C., Gerber, B., Klare, P., Kümmel, S., Schem, C., Paepke, S., Schmutzler, R., Rhiem, K., Penn, S., Reid, J., Nekljudova, V., Hartman, A.-R., von Minckwitz, G., Untch, M.

Volltext

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and b... von Loibl, S., Untch, M., Burchardi, N., Huober, J., Sinn, B.V., Blohmer, J.-U., Grischke, E.-M., Furlanetto, J., Tesch, H., Hanusch, C., Engels, K., Rezai, M., Jackisch, C., Schmitt, W.D., von Minckwitz, G., Thomalla, J., Kümmel, S., Rautenberg, B., Fasching, P.A., Weber, K., Rhiem, K., Denkert, C., Schneeweiss, A.

Volltext

The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial von Jaeger, B A S, Neugebauer, J, Andergassen, U, Melcher, C, Schochter, F, Mouarrawy, D, Ziemendorff, G, Clemens, M, V Abel, E, Heinrich, G, Schueller, K, Schneeweiss, A, Fasching, P, Beckmann, M W, Scholz, Ch, Friedl, T W P, Friese, K, Pantel, K, Fehm, T, Janni, W, Rack, B

Volltext

Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study von Huybrechts, K F, Gerhard, T, Crystal, S, Olfson, M, Avorn, J, Levin, R, Lucas, J A, Schneeweiss, S

Volltext

Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs von Lin, KJ, Schneeweiss, S

Volltext

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study) von Fasching, P.A., Link, T., Hauke, J., Seither, F., Jackisch, C., Klare, P., Schmatloch, S., Hanusch, C., Huober, J., Stefek, A., Seiler, S., Schmitt, W.D., Uleer, C., Doering, G., Rhiem, K., Schneeweiss, A., Engels, K., Denkert, C., Schmutzler, R.K., Hahnen, E., Untch, M., Burchardi, N., Blohmer, J.-U., Loibl, S.

Volltext

New neutron-deficient tellurium, iodine, and xenon isotopes produced by reactions of 290 MeV 58Ni ions on 58Ni and 63Cu targets von Kirchner, R., Klepper, O., Nyman, G., Reisdorf, W., Roeckl, E., Schardt, D., Kaffrell, N., Peuser, P., Schneeweiss, K.

Volltext

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response von Loibl, S., Schneeweiss, A., Huober, J., Braun, M., Rey, J., Blohmer, J.-U., Furlanetto, J., Zahm, D.-M., Hanusch, C., Thomalla, J., Jackisch, C., Staib, P., Link, T., Rhiem, K., Solbach, C., Fasching, P.A., Nekljudova, V., Denkert, C., Untch, M.

Volltext

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally adv... von Miles, D., Gligorov, J., Cameron, D., Xu, B., Semiglazov, V., Reinisch, M., Patre, M., Morales, L., Patel, S.L., Barata, T., Xu, B., Shao, Z., Wang, X., Geng, C., Yan, X., Tong, Z., Sun, T., Yang, J., Liu, Q., Zhang, S., De Laurentiis, M., Santoro, A., Colleoni, M., Cortesi, L., Placido, S., Ferrau, F., Del Mastro, L., Tonini, G., Montemurro, F., Bianchi, G., Prete, S., Allegrini, G., Naso, G., Vici, P., Loirat, D., Tredan, O., Gligorov, J., Timar David, M., Dohollou, N., Spano, J.-P., Mansi, L., Andrade, L., Damian, F., Aleixo, S., Junior, R., Reinisch, M., Grischke, E.-M., Harbeck, N., Peters, U., Fischer, D., Forstbauer, H., Warner, E., Bouganim, N., Vandenberg, T., Pavic, M., Robinson, A., Califaretti, N., Alacacioglu, A., Gumus, M., Yalcin, B., Cicin, I., Kose, F., Cubukcu, E., Wardley, A., Miles, D., Gupta, S., Mohapatra, P., Ghadyalpatil, N., Singhal, M., Agarwal, A., Wolf, I., Gal Yam, E., Yerushalmi, R., Peretz, T., Ben Baruch, N., Hamilton, E., Brufsky, A., Wright, G., Graff, S., Semiglazov, V., Ruiz Borrego, M., Merino, L., Guerra Martinez, J., Ohtani, S., Inoue, K., Ito, Y., Niikura, N., Sagara, Y., Yanagita, Y., Kaen, D., Nervo, A., Melichar, B., Sormova, P., Sufliarsky, J., Kakalejcik, M., Belbaraka, R., Errihani, H., Le Than, D., Pham, D., Papandreou, C.

Volltext

From adaptive licensing to adaptive pathways: Delivering a flexible life-span approach to bring new drugs to patients von Eichler, H-G, Baird, LG, Barker, R, Bloechl-Daum, B, Børlum-Kristensen, F, Brown, J, Chua, R, Del Signore, S, Dugan, U, Ferguson, J, Garner, S, Goettsch, W, Haigh, J, Honig, P, Hoos, A, Huckle, P, Kondo, T, Le Cam, Y, Leufkens, H, Lim, R, Longson, C, Lumpkin, M, Maraganore, J, O'Rourke, B, Oye, K, Pezalla, E, Pignatti, F, Raine, J, Rasi, G, Salmonson, T, Samaha, D, Schneeweiss, S, Siviero, PD, Skinner, M, Teagarden, JR, Tominaga, T, Trusheim, MR, Tunis, S, Unger, TF, Vamvakas, S, Hirsch, G

Volltext

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo von Karn, T., Denkert, C., Weber, K.E., Holtrich, U., Hanusch, C., Sinn, B.V., Higgs, B.W., Jank, P., Sinn, H.P., Huober, J., Becker, C., Blohmer, J.-U., Marmé, F., Schmitt, W.D., Wu, S., van Mackelenbergh, M., Müller, V., Schem, C., Stickeler, E., Fasching, P.A., Jackisch, C., Untch, M., Schneeweiss, A., Loibl, S.

Volltext

Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe von Vreman, Rick A., Naci, Huseyin, Goettsch, Wim G., Mantel‐Teeuwisse, Aukje K., Schneeweiss, Sebastian G., Leufkens, Hubert G. M., Kesselheim, Aaron S.

Volltext

Footprints of parasitism in the genome of the parasitic flowering plant Cuscuta campestris von Vogel, Alexander, Schwacke, Rainer, Denton, Alisandra K., Usadel, Björn, Hollmann, Julien, Fischer, Karsten, Bolger, Anthony, Schmidt, Maximilian H.-W., Bolger, Marie E., Gundlach, Heidrun, Mayer, Klaus F. X., Weiss-Schneeweiss, Hanna, Temsch, Eva M., Krause, Kirsten

Volltext

Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade von Hennigs, A., Riedel, F., Marmé, F., Sinn, P., Lindel, K., Gondos, A., Smetanay, K., Golatta, M., Sohn, C., Schuetz, F., Heil, J., Schneeweiss, A.

Volltext

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer von Swain, Sandra M, Baselga, José, Kim, Sung-Bae, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas, Heeson, Sarah, Clark, Emma, Ross, Graham, Benyunes, Mark C, Cortés, Javier

Volltext